Brian Rago
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Drug Transport and Resistance Mechanisms
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 7
- HER2/EGFR in Cancer Research 7
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Xiaogang Han (6 shared papers)L. Nathan Tumey (6 shared papers)Tracey Clark (4 shared papers)Frank Barletta (4 shared papers)Cexiong Fu (1 shared paper)Cong Wei (3 shared papers)Steven Hansel (2 shared papers)Ragu Ramanathan (3 shared papers)
- Journals
- Bioanalysis (6 papers)Bioconjugate Chemistry (3 papers)Clinical Pharmacology & Therapeutics (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesFinlandJapan
In The Last Decade
Brian Rago
20 papers receiving 515 citations
Peers
Comparison fields: 5 of 73
- Oncology 316
- Radiology, Nuclear Medicine and Imaging 192
- Pharmacology 69
- Pharmaceutical Science 41
- Pediatrics, Perinatology and Child Health 64
Countries citing papers authored by Brian Rago
This map shows the geographic impact of Brian Rago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Rago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Rago more than expected).
Fields of papers citing papers by Brian Rago
This network shows the impact of papers produced by Brian Rago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Rago. The network helps show where Brian Rago may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Rago, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 83 | |
| 2 | 2016 | 73 | |
| 3 | 2013 | 52 | |
| 4 | 2017 | 49 | |
| 5 | 2020 | 36 | |
| 6 | 2013 | 33 | |
| 7 | 2015 | 31 | |
| 8 | 2017 | 27 | |
| 9 | 2016 | 26 | |
| 10 | 2016 | 21 | |
| 11 | 2009 | 18 | |
| 12 | 2015 | 18 | |
| 13 | 2018 | 17 | |
| 14 | 2018 | 16 | |
| 15 | 2011 | 14 | |
| 16 | 2023 | 9 | |
| 17 | 2021 | 8 | |
| 18 | 2016 | 6 | |
| 19 | 2016 | 3 | |
| 20 | 2018 | 2 |
About Brian Rago
Brian Rago is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 542 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (7 papers), Metabolism and Genetic Disorders (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Advanced Drug Delivery Systems (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Oncology (316 citations), Radiology, Nuclear Medicine and Imaging (192 citations), Pharmacology (69 citations), Pharmaceutical Science (41 citations) and Pediatrics, Perinatology and Child Health (64 citations). Brian Rago has collaborated with scholars based in United States, Finland and Japan. Frequent co-authors include Xiaogang Han, L. Nathan Tumey, Tracey Clark, Frank Barletta, Cexiong Fu, Cong Wei, Steven Hansel, Ragu Ramanathan, A. David Rodrigues and Guodong Zhang. Their work appears in journals such as Bioanalysis, Bioconjugate Chemistry, Clinical Pharmacology & Therapeutics, Molecular Cancer Therapeutics and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.